Cargando…
Minimal clinically important difference for asthma endpoints: an expert consensus report
Minimal clinically important difference (MCID) can be defined as the smallest change or difference in an outcome measure that is perceived as beneficial and would lead to a change in the patient's medical management. The aim of the current expert consensus report is to provide a “state-of-the-a...
Autores principales: | Bonini, Matteo, Di Paolo, Marcello, Bagnasco, Diego, Baiardini, Ilaria, Braido, Fulvio, Caminati, Marco, Carpagnano, Elisiana, Contoli, Marco, Corsico, Angelo, Del Giacco, Stefano, Heffler, Enrico, Lombardi, Carlo, Menichini, Ilaria, Milanese, Manlio, Scichilone, Nicola, Senna, Gianenrico, Canonica, Giorgio W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488652/ https://www.ncbi.nlm.nih.gov/pubmed/32499305 http://dx.doi.org/10.1183/16000617.0137-2019 |
Ejemplares similares
-
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly
por: Scichilone, Nicola, et al.
Publicado: (2015) -
The perception of Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) among Italian general practitioners
por: Lombardi, Carlo, et al.
Publicado: (2015) -
Effects of aclidinium on determinants of COPD severity: symptoms and quality of life
por: Contoli, Marco, et al.
Publicado: (2016) -
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life()
por: Bagnasco, Diego, et al.
Publicado: (2021) -
Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective
por: Caminati, Marco, et al.
Publicado: (2023)